β-Adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure

Although the widespread introduction of beta-adrenoceptor antagonists into the management of congestive heart failure (CHF) has led to significant improvements in morbidity and mortality, it is also apparent that clinical responses to this therapy vary substantially. With the recognition that functi...

Ausführliche Beschreibung